Toronto - Free Realtime Quote CAD
HLS Therapeutics Inc. (HLS.TO)
4.6100
-0.0400
(-0.86%)
As of 1:34:44 PM EDT. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.15 | -0.15 | -0.59 | -0.17 |
| Low Estimate | -0.15 | -0.15 | -0.59 | -0.17 |
| High Estimate | -0.15 | -0.15 | -0.59 | -0.17 |
| Year Ago EPS | -0.29 | -- | -0.62 | -0.59 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 2 | 4 |
| Avg. Estimate | 14.6M | 14.3M | 58M | 63.55M |
| Low Estimate | 14M | 14M | 57.8M | 60.3M |
| High Estimate | 15.3M | 14.9M | 58.2M | 66.3M |
| Year Ago Sales | 14.52M | 14.09M | 56.62M | 58M |
| Sales Growth (year/est) | 0.56% | 1.53% | 2.44% | 9.57% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.18 | -0.14 | -0.09 | -0.17 |
| EPS Actual | -0.29 | -0.15 | -0.1 | -0.14 |
| Difference | -0.11 | -0.01 | -0.01 | 0.03 |
| Surprise % | -59.17% | -7.14% | -11.11% | 17.65% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.15 | -0.15 | -0.59 | -0.17 |
| 7 Days Ago | -0.15 | -0.15 | -0.59 | -0.23 |
| 30 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
| 60 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
| 90 Days Ago | -0.09 | -0.09 | -0.36 | -0.23 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | 1 |
| Down Last 30 Days | -- | -- | 1 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| HLS.TO | 47.64% | -- | 4.84% | 71.19% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Maintains | Raymond James: Market Perform to Market Perform | 3/18/2024 |
| Downgrade | Raymond James: Outperform to Market Perform | 8/6/2021 |
Related Tickers
MDP.TO Medexus Pharmaceuticals Inc.
2.8000
-4.11%
KHTRF Knight Therapeutics Inc.
4.4600
+1.83%
RX.V BioSyent Inc.
10.95
+0.92%
CPH.TO Cipher Pharmaceuticals Inc.
13.40
-3.67%
LSL.V LSL Pharma Group Inc.
0.3950
0.00%
MOB.ST Moberg Pharma AB (publ)
7.35
-0.68%
ESPR Esperion Therapeutics, Inc.
0.8090
+1.35%
BIOYF BioSyent Inc.
7.82
+0.26%
CANB.V CanadaBis Capital Inc.
0.0500
0.00%
GUD.TO Knight Therapeutics Inc.
5.83
+2.10%